Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation
- 5 January 2009
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 26 (1), 14-18
- https://doi.org/10.1111/j.1464-5491.2008.02622.x
Abstract
To assess determinants of fetal growth in the offspring of pregnant women with hyperglycaemia due to a heterozygous glucokinase (GCK) gene mutation.Details of gestational age at delivery, fetal birth weight and maternal antenatal treatment were collected from patients and retrospective case note review of 82 offspring born to 42 women with GCK gene mutations and 31 offspring born to 13 unaffected normoglycaemic women with an affected partner. Fetal genotype was determined using direct sequencing from either a mouth swab or a blood sample.In mothers with GCK mutations, non-mutation-carrying offspring were heavier than mutation-carrying offspring (corrected birth weight 3.9 +/- 0.6 vs. 3.2 +/- 0.8 kg; P < 0.001) and more likely to be macrosomic (> 4.0 kg; 39% vs. 7%, P = 0.001). There was no difference in corrected birth weight between offspring of insulin- and diet-treated women (3.7 +/- 0.7 vs. 3.8 +/- 0.6 kg; P = 0.1), although insulin-treated mothers delivered earlier (37.5 +/- 1.7 vs. 38.9 +/- 2.3 weeks; P < 0.001) due to increased obstetric intervention.Offspring of women with GCK mutations are at increased risk of macrosomia and its obstetric consequences. Fetal birth weight is predominantly altered by fetal genotype and not treatment of maternal hyperglycaemia with insulin. This probably reflects the large effect of a fetal GCK mutation on fetal insulin secretion and the difficulty in reducing the regulated maternal glycaemia caused by a glucose sensing defect in people with GCK mutations.Keywords
This publication has 10 references indexed in Scilit:
- The genetic abnormality in the beta cell determines the response to an oral glucose loadDiabetologia, 2002
- A Randomized Controlled Trial Using Glycemic Plus Fetal Ultrasound Parameters Versus Glycemic Parameters to Determine Insulin Therapy in Gestational Diabetes With Fasting HyperglycemiaDiabetes Care, 2001
- Influence of maternal and fetal glucokinase mutations in gestational diabetesAmerican Journal of Obstetrics and Gynecology, 2001
- Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivityDiabetologia, 2000
- Gestational Diabetes MellitusNew England Journal of Medicine, 1999
- Mutations in the glucokinase gene of the fetus result in reduced birth weightNature Genetics, 1998
- Intensified versus conventional management of gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1994
- Use of Fetal Ultrasound to Select Metabolic Therapy for Pregnancies Complicated by Mild Gestational DiabetesDiabetes Care, 1994
- Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.JCI Insight, 1994
- Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy StudyAmerican Journal of Obstetrics and Gynecology, 1991